Rise Advisors’s Qiagen QGEN Stock Holding History

Rise Advisors’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21	Closed	-$1.01K	–	773
2023 Q1	$1.01K	Hold	21	–	–	﹤0.01%	659
2022 Q4	$7.1K	Hold	21	–	–	0.01%	401
2022 Q3	$1K	Buy	+21	New	+$1.04K	﹤0.01%	662

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rise Advisors's QGEN Position: Q2 2023 in Review

Rise Advisors sold out of Qiagen (QGEN) in Q2 2023, closing a stake of 21 shares — an estimated $1.01K sold.

Rise Advisors first reported a position in QGEN in Q3 2022 and held it in 3 quarters. The position peaked at $7.1K in Q4 2022. 282 funds tracked by Wall St. Rank hold QGEN as of Q2 2023.

Rise Advisors reported no remaining Qiagen position as of Q2 2023 after selling out during the quarter.
Rise Advisors sold 21 Qiagen shares in Q2 2023, an estimated $1.01K.
Rise Advisors first reported a position in Qiagen in Q3 2022 and held it in 3 quarters.
Rise Advisors's Qiagen position peaked at $7.1K in Q4 2022.
282 funds tracked by Wall St. Rank held Qiagen as of Q2 2023.

Based on Rise Advisors's 13F filing for Q2 2023, filed 10 Jul 2023.